MBX Biosciences

MBX Biosciences

MBX Biosciences

MBX Biosciences is a preclinical-stage biotech company that creates therapies to treat rare endocrine diseases.
Founded
2019
Raised
$34.6M
Follow us
Latest funding
$34,600,000
Venture capital (Series A) - 2020
Frazier Healthcare Partners OrbiMed BioCrossroads +3
Team Size
1–10
Employees
$34,600,000 Venture capital (Series A)
FinSMEs

MBX Biosciences Closes $34.6M Series A Financing